BJU International
Journal
-
- Overview
-
- Identity
-
- View All
-
Overview
publication venue for
-
The cytoreductive prostatectomy in metastatic prostate cancer: what the individual trials are hoping to answer.
125:792-800.
2020
-
Metformin may offer no protective effect in men undergoing external beam radiation therapy for prostate cancer.
123:36-42.
2019
-
The trajectory of people who die from metastatic prostate cancer: A population-based study..
123:19-26.
2019
-
Trends in incidence and survival for upper tract urothelial cancer (UTUC) in the state of Victoria - Australia.
117:45-49.
2016
-
Cognitive existential couple therapy (CECT) in men and partners facing localised prostate cancer: a randomised controlled trial.
115:35-45.
2015
-
Patterns of care for metastatic renal cell carcinoma in Australia.
116:36-41.
2015
-
Population-based analysis of prostate-specific antigen (PSA) screening in younger men (<55 years) in Australia.
113:77-83.
2014
-
Bladder carcinoma in situ (CIS) in Australia: a rising incidence for an under-reported malignancy.
112:46-52.
2013
-
Incidence of prostate cancer in Sri Lanka using cancer registry data and comparisons with the incidence in South Asian men in England.
108:E184-E189.
2011
-
Effects of bariatric surgery on urinary and sexual function.
107:88-94.
2011
-
National prevalence of urogenital pain and prostatitis-like symptoms in Australian men using the National Institutes of Health Chronic Prostatitis Symptoms Index.
105:373-379.
2010
-
ANTIBIOTICS FOR TRANSRECTAL ULTRASONOGRAPHY-GUIDED PROSTATE BIOPSY: ARE WE PRACTISING EVIDENCE-BASED MEDICINE?.
101:1202-1204.
2008
-
Positron emission tomography (PET), immuno-PET and radioimmunotherapy in renal cell carcinoma: a developing diagnostic and therapeutic relationship.
97:916-922.
2006
-
Positron emission tomography and molecular imaging of the prostate: an update.
97:923-931.
2006
-
An analysis of deaths related to urological surgery, reviewed by the State Coroner: a case for cardiac vigilance before transurethral prostatectomy.
97:758-761.
2006
-
Assessing regional hypoxia in human renal tumours using 18F-fluoromisonidazole positron emission tomography.
96:540-546.
2005
-
Sacral nerve root stimulation for lower urinary tract dysfunction: overcoming the problem of lead migration.
87:15-18.
2001
-
A novel framework for automated, intelligent extraction and analysis of online support group discussions for cancer related outcomes
2017
-
Epithelial estrogen receptor a (ER alpha) regulates the proliferation of prostate cancer cells
2013
-
Gender-related bladder cancer outcomes in Victoria, Australia
2019
-
Robotic-assisted laparoscopic prostatectomy vs open radical prostatectomy: the "real life" patient reported outcomes
2018
-
Survival outcomes of younger men (< 55 years) undergoing radical prostatectomy
2018
-
Is there any value in the routine histopathological analysis of pyeloplasty specimens or a waste of resources?
2018
-
Metformin offers no protective effect in men undergoing external beam radiation therapy for prostate cancer
2018
-
Primary healthcare screening of prostate cancer: the impact of clinical practice guidelines
2018
-
DNA repair gene defects in Australian men with metastatic castration-resistant prostate cancer (mCRPC)
2017
-
Hospital episode costs: a practical framework in a Victorian public hospital
2017
-
Can Transrectal Ultrasound guided biopsy (TRUS) reporting standards affect decision-making in men opting for active surveillance?
2017
-
Female gender is associated with higher mortality after radical cystectomy for organ-confined bladder cancers in UK: a population-based study
2017
-
Prone vs modified supine percutaneous nephrolithotomy (PCNL): which is more cost effective in a tertiary teaching hospital in Victoria, Australia?
2017
-
Quantifying pelvic muscle tone with functional studies to improve the diagnostic accuracy of Overactive Pelvic Floor Muscles (OPFM)
2017
-
Survival outcomes in men > 75 following radical prostatectomy in Victoria
2017
-
Survival outcomes in older men undergoing radical prostatectomy in Victoria
2016
-
Utility of intra-operative ureteral frozen section analysis
2016
-
Patient participation in the decision-making process of localised prostate cancer treatment-the decision-making role of the patient
2016
-
Imaging in the staging of low/intermediate risk prostate cancer: are we observing current guidelines?
2015
-
Radiation exposure to the urologist during PCNL: is modified supine position superior to prone position?
2015
-
Renal cell and upper tract urothelial carcinomas: trends in survival in Victoria, Australia
2015
-
Comparison of long-term surgical outcomes between PVP (120 W) and TURP
2015
-
Intravesical Bacillus Calmette-Guerin for non-muscle invasive urothelial carcinoma of the bladder - patterns of use, and impact on outcomes
2015
-
Is pre-operative MSU or stone culture better at predicting post-PCNL sepsis?
2015
-
Surgical outcomes of modified supine vs prone PCNL: a prospective cohort study
2015
-
The accuracy of visual detection of high-risk superficial bladder transitional cell carcinoma (TCC) after Bacillus-Calmette-Guerin (BCG) treatment
2015
-
A comparison of 11C-choline PET with T2-weighted MRI for localizing malignant intraprostatic lesions for guiding prostate cancer focal therapies
2014
-
Stage I seminoma - treatment choices and outcomes at a single tertiary referral institution
2014
-
Hypoxia Inducible Factor 1 alpha (HIF1 alpha) increases risk of metastases in men with locally advanced high risk prostate cancer
2014
-
Angiotensin converting enzyme (ACE) inhibitors: impact on men receiving primary radiotherapy (RT) for prostate cancer (PC)
2013
-
Non-specific HIF1 alpha inhibitors in men receiving androgen deprivation therapy for prostate cancer
2013
-
PET/CT predicts mortality in muscle invasive bladder cancer
2013
-
The experiences of gay and bisexual men diagnosed with prostate cancer: Results from an online focus group
2013
-
Positron emission tomography-computed tomography (PET-CT) role in predicting mortality in patients with metastatic bladder cancer
2012
-
In-vivo imaging of cellular proliferation in renal cell carcinoma using [18]F fluorothymidine PET
2010
-
In vivo measurement of hypoxia in a renal cell carcinoma xenograft model
2009
-
The role of interventional radiology in the management of renal trauma: five year experience in a level I trauma centre
2009
-
In vivo molecular imaging of proliferation in renal cell carcinoma using F-18-fluorodeoxythymidine (FLT) positron emission tomography
2007
-
A novel method for transplanting a reproducible volume of xenograft tumour beneath the renal capsule using automated biopsy equipment and an epidural needle
2006
-
In vivo tumour hypoxia and carbonic anhydrase IX expression in xenografted human renal cell carcinoma animal models using probes, I-124-G250 pet, biodistribution and immunohisto-chemistry immunobiodistribution, and oxygen studies
2006
-
Serum osteopontin - a new tumour marker in renal cell carcinoma
2005
-
Examining completeness and agreement of comorbidity data obtained from administrative data, medical records and selfâreports by men diagnosed with prostate cancer undergoing radical prostatectomy
2019
-
Current practice in screening for prostate cancer in primary care
2014
-
Is choline-based PET imaging still relevant in recurrent prostate cancer?.
120:303-304.
2017
has subject area
Identity
International Standard Serial Number (ISSN)
Electronic International Standard Serial Number (EISSN)